Switching from a ritonavir-boosted protease inhibitor to a dolutegravir-based regimen for maintenance of HIV viral suppression in patients with high cardiovascular risk (Q47145824)
Jump to navigation
Jump to search
scientific article published on 2 November 2017
Language | Label | Description | Also known as |
---|---|---|---|
English | Switching from a ritonavir-boosted protease inhibitor to a dolutegravir-based regimen for maintenance of HIV viral suppression in patients with high cardiovascular risk |
scientific article published on 2 November 2017 |
Statements
1 reference
Switching from a ritonavir-boosted protease inhibitor to a dolutegravir-based regimen for maintenance of HIV viral suppression in patients with high cardiovascular risk (English)
1 reference
Hans-Jürgen Stellbrink
1 reference
Stephane De Wit
1 reference
François Raffi
1 reference
José M Gatell
1 reference
Lambert Assoumou
1 reference
Graeme Moyle
1 reference
Laura Waters
1 reference
Margaret Johnson
1 reference
Pere Domingo
1 reference
Julie Fox
1 reference
Esteban Martinez
1 reference
Giovanni Guaraldi
1 reference
Mar Masia
1 reference
Mark Gompels
1 reference
Eric Florence
1 reference
Stefan Esser
1 reference
Anton L Pozniak
1 reference
NEAT022 Study Group*
1 reference
2 November 2017
1 reference
1 reference
31
1 reference
18
1 reference
2503-2514
1 reference
Identifiers
1 reference